Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-06
2007-02-06
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S215000, C548S243000, C548S416000, C548S427000, C548S450000, C546S276700, C514S374000, C514S378000, C514S411000
Reexamination Certificate
active
10450639
ABSTRACT:
Compounds of formula (I)and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
REFERENCES:
patent: 6018068 (2000-01-01), Nagao et al.
patent: 6861441 (2005-03-01), Clayton et al.
patent: 6924297 (2005-08-01), Giblin et al.
patent: 0 845 451 (1988-06-01), None
patent: WO 00/18744 (2000-04-01), None
Frye Stephen Vernon
Giblin Gerard Martin Paul
Roomans Susan
Glaxo Group Limited
Hsu Grace C.
Kinzig Charles M.
McCarthy Mary E.
Shameem Golam M. M.
LandOfFree
Benzo (f) insoindol derivatives and their use as ep4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo (f) insoindol derivatives and their use as ep4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo (f) insoindol derivatives and their use as ep4... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3872245